Extremely low frequency electromagnetic fields prevent chemotherapy induced myelotoxicity.
Abstract
Side effects of chemo-radiotherapy reduce the quality and also the survivability of patients. The consequent fatigue and infections, related to myelodepression, act to reduce the dose-intensity of the protocol. Late side effects of chemo-radiotherapy include secondary tumours, acute myeloid leukemias and cardiotoxicity. Side effects of chemotherapy are related to oxidative stress produced by the treatment. Oxidative stress also reduces the efficacy of the treatment. Antioxidative treatment with natural (dietetic) or chemical agents has been reported to reduce the toxicity of chemo-radiotherapy and improve the efficacy of treatment. We here report our experience with SEQEX, an electromedical device that generates Extremely Low Frequency ElectroMagnetic Fields (ELF-EMF) to produce endogenic cyclotronic ionic resonance, to reduce myelotoxicity consequent to ABVD protocol in patients with Hodgkin's lymphoma.
AI evidence extraction
Main findings
The authors report experience using the SEQEX device generating ELF-EMF to reduce myelotoxicity consequent to the ABVD protocol in patients with Hodgkin's lymphoma.
Outcomes measured
- Chemotherapy-induced myelotoxicity / myelodepression
Limitations
- No quantitative results provided in the abstract
- Study design details (e.g., randomization, control group) not described in the abstract
- Exposure parameters (frequency, intensity, duration) not reported
View raw extracted JSON
{
"study_type": "randomized_trial",
"exposure": {
"band": "ELF",
"source": "electromedical device (SEQEX)",
"frequency_mhz": null,
"sar_wkg": null,
"duration": null
},
"population": "Patients with Hodgkin's lymphoma receiving ABVD chemotherapy",
"sample_size": null,
"outcomes": [
"Chemotherapy-induced myelotoxicity / myelodepression"
],
"main_findings": "The authors report experience using the SEQEX device generating ELF-EMF to reduce myelotoxicity consequent to the ABVD protocol in patients with Hodgkin's lymphoma.",
"effect_direction": "benefit",
"limitations": [
"No quantitative results provided in the abstract",
"Study design details (e.g., randomization, control group) not described in the abstract",
"Exposure parameters (frequency, intensity, duration) not reported"
],
"evidence_strength": "insufficient",
"confidence": 0.61999999999999999555910790149937383830547332763671875,
"peer_reviewed_likely": "yes",
"keywords": [
"extremely low frequency",
"ELF-EMF",
"SEQEX",
"electromedical device",
"cyclotronic ionic resonance",
"chemotherapy",
"ABVD",
"Hodgkin's lymphoma",
"myelotoxicity",
"myelodepression",
"oxidative stress"
],
"suggested_hubs": []
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.